ENDOCRINOLOGIST

Dr. Green is an Endocrinologist and Professor of Medicine at Duke University and a member of the Duke Clinical Research Institute (DCRI). Her research has focused upon strategies to treat diabetes mellitus and reduce the risk of CV, kidney and other complications. She is an Executive Committee Member for GRADE, a long-term comparative effectiveness study of medications for T2D, and has held leadership roles in numerous large, international trials studying the CV effects of newer glucose-lowering medications (including TECOS, EXSCEL, and Harmony Outcomes). She is Executive Committee member, PI of the US coordinating center, and country representative for the global EMPA-Kidney and EASi-Kidney trials. She has held multiple roles with the American Diabetes Association, including serving on the organization’s Professional Practice Committee, as a member of the ADA-EASD consensus statement writing group, and as an Associate Editor of Diabetes Care. She is currently President-Elect, Medicine and Science, for the ADA.

CARDIOLOGIST

Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Cardiology. He also serves as the Lead Physician for the Parkland Health Outpatient Cardiology Clinic.

Originally from Fayetteville, Arkansas, Dr. McGuire holds a bachelor’s degree in chemistry from Hendrix College in Conway. He earned his medical degree at the Johns Hopkins University School of Medicine in Baltimore and completed internal medicine residency training at UT Southwestern. He then received advanced training in cardiology through a fellowship at Duke University in Durham, North Carolina, where he also conducted research for two years, working on a number of large-scale, international clinical trials and registries at the Duke Clinical Research Institute (DCRI). He also earned a master’s degree in health sciences in clinical trials at the Duke University School of Medicine.

Dr. McGuire joined the UT Southwestern faculty in 2001. His main clinical and research interests are in the long-term prevention of and risk-modification for cardiovascular disease, especially among patients with diabetes. His research has led to more than 100 publications in peer-reviewed journals. 

Dr. McGuire is Deputy Editor of Circulation, Senior Editor of Diabetes and Vascular Disease Research, and editor of the textbook Diabetes in Cardiovascular Disease: a companion to Braunwald’s Heart Disease.

He is a Fellow of the American Heart Association (AHA), the American College of Cardiology and the European Society of Cardiology; a former Chair of the AHA Diabetes Committee; and a former member of and present ad hoc consultant for the FDA Cardiovascular and Renal Drugs Advisory Committee.

Dr. McGuire has received numerous teaching awards, most notably the UT System Board of Regents Outstanding Teaching Award in 2013.

ENDOCRINOLOGIST

Lawrence A Leiter MD FRCPC FACP FACE FAHA FACC FCAHS

 Dr. Lawrence A. Leiter is Director of the Lipid Clinic; Associate Director of the Clinical Nutrition and Risk Factor Modification Centre; and Associate Scientist, Li Ka Shing Knowledge Institute at St. Michael’s Hospital in Toronto where he was also the Head of the Division of Endocrinology and Metabolism from 2000-2010. He is a Professor in the Departments of Medicine and Nutritional Sciences at the University of Toronto.

Dr. Leiter has several research interests including clinical trials on the prevention of atherosclerosis, especially in diabetes, and the dietary and pharmacologic treatment of diabetes mellitus, hyperlipidemia, hypertension, and obesity. He has over 900 publications in peer-reviewed journals including 37 in the New England Journal of Medicine, 26 in Lancet and 20 in JAMA. He was involved in many of the major multi-centre trials (DCCT, ACCORD and ADVANCE) that established early diabetes care as the standard of practice, and has played a leadership role in many of the more recent outcome trials that have contributed to major changes in the management of patients with diabetes and/or lipid disorders. For 7 consecutive years (2018-2024) he was a Clarivate Analytics Top 1% Highly Cited Researcher.

Dr. Leiter is a Past-President of the Canadian Society of Endocrinology & Metabolism (CSEM) and a past Chair of the Clinical and Scientific Section of the Canadian Diabetes Association (CDA). He has been involved in many national and international guidelines and consensus conferences including those of the International Diabetes Federation, CDA, Canadian Hypertension Education Program (CHEP), Canadian Cardiovascular Society (Dyslipidemia), and Obesity Canada. He is a past Associate Editor of the journal Diabetes Care.

For his work, he has received a number of awards including the CDA Frederick G. Banting Award and the American Diabetes Association Charles H Best Award (awarded to DCCT investigators), both for Distinguished Service, the 2005 CSEM Educator of the Year Award, and the 2006 CDA Gerald S. Wong Award in recognition of significant contributions to the diabetes community. He was the inaugural winner of the St. Michael’s Hospital Complete Physician Award in 2009. He is also the 2016 recipient of both the CDA Lifetime Achievement Award for Research Excellence and the CSEM Robert Volpe Distinguished Service Award. In 2019 was elected as a Fellow of the Canadian Academy of Health Sciences.